Discrete Choice Experiment to Understand Japanese Patients' and Physicians' Preferences for Preventive Treatments for Migraine.
Jaein SeoTommi TervonenKaname UedaDian ZhangDaisuke DannoAntje Tockhorn-HeidenreichPublished in: Neurology and therapy (2023)
Many patients and physicians preferred CGRP mAb auto-injectors over non-CGRP oral medications and preferred a treatment profile similar to galcanezumab. Our results may encourage physicians in Japan to consider patient preferences when recommending migraine preventive treatments.